Anticoagulation use and the risk of stroke and major bleeding in patients on hemodialysis: From the VIVALDI, a population‐based prospective cohort study
Open Access
- 21 August 2021
- journal article
- research article
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 19 (12) , 2984-2996
Abstract
No abstract availableKeywords
Funding Information
- Austrian Science Fund (SFB 54)
- Oesterreichische Nationalbank
- Clinical Center (R01DK095024)
This publication has 40 references indexed in Scilit:
- Stroke and Bleeding in Atrial Fibrillation with Chronic Kidney DiseaseNew England Journal of Medicine, 2012
- Chronic Kidney Disease Is Associated With the Incidence of Atrial FibrillationCirculation, 2011
- Atrial fibrillation in hemodialysis patients: clinical features and associations with anticoagulant therapyKidney International, 2010
- Warfarin Use Associates with Increased Risk for Stroke in Hemodialysis Patients with Atrial FibrillationJournal of the American Society of Nephrology, 2009
- Atrial fibrillation in incident dialysis patientsKidney International, 2009
- Impact of Proteinuria and Glomerular Filtration Rate on Risk of Thromboembolism in Atrial FibrillationCirculation, 2009
- Dialysis Accelerates Medial Vascular Calcification in Part by Triggering Smooth Muscle Cell ApoptosisCirculation, 2008
- Chronic Kidney Disease and the Risks of Death, Cardiovascular Events, and HospitalizationNew England Journal of Medicine, 2004
- Elevated risk of stroke among patients with end-stage renal diseaseKidney International, 2003
- Incidence of Stroke among Chronic Hemodialysis Patients with Nonrheumatic Atrial FibrillationAmerican Journal of Nephrology, 2001